Amphastar Pharmaceuticals, Inc. Other Non-Current Assets
Amphastar Pharmaceuticals, Inc. (AMPH) had Other Non-Current Assets of $33.39 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $33.39M.
- 2026-03-31: Other Assets, Noncurrent $33.48M.
- 2025-12-31: Other Assets, Noncurrent $31.14M.
- 2025-09-30: Other Assets, Noncurrent $29.87M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $33.39M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $33.48M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $31.14M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $29.87M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $28.10M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $22.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $25.99M 10-K · filed 2026-02-26 |
| 2024-09-30 | $23.66M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $24.26M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $23.37M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $25.91M 10-K · filed 2025-03-03 |
| 2023-09-30 | $25.30M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $20.27M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $18.54M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $20.86M 10-K · filed 2024-02-29 |
| 2022-09-30 | $20.55M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $18.68M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.30M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $16.66M 10-K · filed 2023-03-01 |
| 2021-09-30 | $11.61M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $9.44M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $7.21M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $5.25M 10-K · filed 2022-03-11 |
| 2020-09-30 | $7.74M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $12.63M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $11.19M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $11.16M 10-K · filed 2021-03-15 |
| 2019-09-30 | $12.33M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $13.52M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $12.29M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $9.92M 10-K · filed 2020-03-16 |
| 2018-09-30 | $11.13M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $11.75M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $10.71M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $8.66M 10-K · filed 2019-03-15 |
| 2017-09-30 | $10.62M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $10.96M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.94M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $9.39M 10-K · filed 2018-03-14 |
| 2016-09-30 | $7.54M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.88M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $5.41M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.70M 10-K · filed 2017-03-15 |
| 2015-09-30 | $4.36M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $4.96M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $4.45M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $3.59M 10-K · filed 2016-03-15 |
| 2014-09-30 | $2.50M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $3.60M 10-Q · filed 2014-08-13 |
| 2013-12-31 | $2.88M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |